Horwitz SM, Scarisbrick JJ, Dummer R, et al. Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician’s choice in cutaneous T-cell lymphoma: final data. Blood Adv.2021;5(23):5098-5106.

Zdroj: Blood Advances; 20240101, Issue: Preprints
Databáze: Supplemental Index
Externí odkaz: